Eton Pharmaceuticals

Eton Pharmaceuticals

ETON· Manufacturing· Fiscal year ends in December

CEO pay in FY2025Stock +27.0% in FY2025

Sean E. Brynjelsen is the CEO of Eton Pharmaceuticals and was paid $2.9M in FY2025 (Dec), up 21%.

Pay$100 in the stock at the end of FY21 → $394
CEO pay is from each Eton Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives4

See all
  1. 1Sean E. BrynjelsenFY2025
  2. 2James R. GruberFY2025
  3. 3David C. KrempaFY2025
  4. 4Ipek Erdogan-TrinkausFY2025

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Pay

See all

Eton Pharmaceuticals paid its 4 named executives $6.3M in total in FY2025 (Dec). CEO Sean E. Brynjelsen was paid $2.9M of that.

Name
Sean E. BrynjelsenPresident and Chief Executive Officer
James R. GruberChief Financial Officer
David C. KrempaChief Business OfficerNot disclosed
Ipek Erdogan-TrinkausChief Commercial Officer

of each named executive, from the Summary Compensation Table of each proxy.

Peers

No disclosed peer group

No proxy on file names a pay peer group for Eton Pharmaceuticals. The peer group comes from the proxy statement, so it shows here when a proxy read has it.

Board4

See all
  • Norbert G. Riedel, Ph.D.Chair · 8 yr on the boardIndependentAudit, Compensation, Nominating and Corporate Governance (Chair)—Paid as an executive
  • Charles J. CasamentoDirector · 8 yr on the boardIndependentAudit, Compensation (Chair), Nominating and Corporate Governance—Paid as an executive
  • Paul V. MaierDirector · 8 yr on the boardIndependentAudit (Chair), Compensation, Nominating and Corporate Governance—Paid as an executive
  • Jenn AdamsDirector · 4 yr on the boardIndependentAudit, Compensation, Nominating and Corporate Governance—Paid as an executive

The board of the latest proxy (FY2025).

Activity

Filings6

See all
Proxy statementDEF 14AApr 24, 2026FY2025
Annual report10-KMar 19, 2026FY2025
Proxy statementDEF 14AApr 25, 2025FY2024
Annual report10-KMar 18, 2025FY2024
Proxy statementDEF 14AApr 26, 2024FY2023
Annual report10-KMar 14, 2024FY2023
For the press:Download CSVDownload PNGHow to use our data